Boehringer Ingelheim International GmbH / Sanofi SA (Merial Animal Health)
2015 · Asset Purchase · $12.4B · Complete
Announcement Sentiment
88
Strongly positive
Boehringer Ingelheim and Sanofi entered a binding business swap: Boehringer acquired Sanofi's Merial animal health business (~euro 11.4B / $12.4B) in exchange for Boehringer's Consumer Healthcare business (~euro 6.7B) plus a euro 4.7B cash payment. Created the world's #2 animal health company. Closed January 1, 2017.
Did it work? Outcome assessment
Strategic verdict
Achieved Stated Rationale
Financial impact
Accretive
Pipeline outcome
Assets Advanced
Assessment window: 5yr post-close.
Key facts
AnnouncedDec 15, 2015
ClosedJan 01, 2017
Deal value$12.4B
Deal typeAsset Purchase
Therapeutic areaCompanion animal and livestock health (parasiticides, vaccines)
IndicationsCompanion animal and livestock health (parasiticides, vaccines)
Key assetsMerial veterinary vaccines and pharmaceuticals (Frontline, NexGard, Heartgard)
MechanismVeterinary vaccines, parasiticides, and pharmaceuticals